Losartan and Tofranil drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Losartan (losartan potassium) and Tofranil (imipramine hydrochloride). Common drug interactions include chronic kidney disease among females and weight decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Losartan and Tofranil. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Losartan?
Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,686 Losartan users. Check the latest studies of Losartan.
What is Tofranil?
Tofranil has active ingredients of imipramine hydrochloride. It is often used in depression. eHealthMe is studying from 2,012 Tofranil users. Check the latest studies of Tofranil.
23 people who take Losartan and Tofranil together, and have interactions are studied.

What are the common drug interactions of Losartan and Tofranil, by gender? *:
female:
- Chronic kidney disease
- Renal failure (kidney dysfunction)
- Death
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Crying
- Fear
- Hyperhidrosis (abnormally increased sweating)
- Memory impairment
male:
- Weight decreased
- Body height decreased
- Pain in extremity
- Platelet count decreased
- Pruritus (severe itching of the skin)
- Red blood cell abnormality (abnormal red blood cells)
- Renal cyst (kidney cyst)
- Renal pain (kidney pain)
- Urinary tract infection
- Vasculitis (inflammation of a blood vessel or blood vessels)
What are the common drug interactions of Losartan and Tofranil, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Body height decreased
- Cardiac disorder
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Dizziness
- Erythema (redness of the skin)
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Impaired healing
- Lipoma (a growth of fatty tissue that slowly develops just under your skin)
- Pain in extremity
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Chronic kidney disease
- Death
- Postoperative abscess
- Renal failure (kidney dysfunction)
60+:
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Panic attack
- Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
- Renal failure (kidney dysfunction)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Death
- Diarrhoea
- Intentional self-injury
What are the existing conditions these people have? *
- Stress And Anxiety: 5 people, 21.74%
- Pain: 4 people, 17.39%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
- Thyroid Diseases: 2 people, 8.70%
- Renal Disorder (kidney disease): 2 people, 8.70%
- Pancreatic Carcinoma (pancreatic cancer): 2 people, 8.70%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.70%
- Infection: 2 people, 8.70%
- High Blood Cholesterol: 2 people, 8.70%
- Diabetes: 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Losartan and Tofranil?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Losartan and Tofranil:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Losartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tofranil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Losartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tofranil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on losartan potassium and imipramine hydrochloride (the active ingredients of Losartan and Tofranil, respectively), and Losartan and Tofranil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Voltaren and Colace - 5 seconds ago
- Could Tasmar cause Cholestasis? - 6 seconds ago
- Could Thalomid cause Osteomyelitis? - 9 seconds ago
- Could Pulmozyme cause Respiratory Tract Infection? - 9 seconds ago
- Could Enoxaparin Sodium cause Pulmonary Oedema? - 12 seconds ago
- Could Imbruvica cause Sepsis? - 12 seconds ago
- Drug interactions of Ativan and Prolixin - 13 seconds ago
- Drug interactions of Femara and Cyclophosphamide - 19 seconds ago
- Could Imbruvica cause Nail Ridging? - 22 seconds ago
- Drug interactions of Nilandron and Lasix - 22 seconds ago